LYRA
NASDAQ · Pharmaceuticals
Lyra Therapeutics Inc
$0.19
+0.00 (+0.00%)
Open$0.03
Previous Close$0.19
Day High$0.19
Day Low$0.03
52W High$6.53
52W Low—
Volume—
Avg Volume1.5K
Market Cap337.2K
P/E Ratio—
EPS$-19.31
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+7,268.4% upside
Current
$0.19
$0.19
Target
$14.00
$14.00
$9.32
$14.00 avg
$16.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 454.7K | 684.9K | 681.7K |
| Net Income | -33,040,711 | -44,790,841 | 169.3K |
| Profit Margin | -7,266.1% | -6,902.8% | 24.8% |
| EBITDA | -34,919,071 | -49,967,039 | 337.6K |
| Free Cash Flow | — | — | 110.0K |
| Rev Growth | -33.6% | -33.6% | +3.7% |
| Debt/Equity | — | — | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |